Other than accelerating NET degradation via DNAse-1, inhibiting NET formation by targeting PAD4 is a feasible strategy: PAD4 overexpression impairs revascularization and vascular remodeling in stroke, while PAD4 inhibition restores angiogenesis (54). The gene discussed is DNASE1; the disease is stroke disorder.